Ann: Excellent SubB2M Breast Cancer Test Data, page-210

Coming up to a year since this announcement came out.

one of the main reasons I hold and keep accumulating is if they can get it to commercialisation.
how many women would go for a yearly blood test that don't want to go get a mammogram. Alot of rural women would have access to be able to give blood for a test that can't access mammograms. Plus if It can detect it years before any visble lumps come up would make for better treatment options.

if they get that shot on goal would be a billion + mcap very easily.
As I keep saying patience will pay off but not overnight.
while it's quiet in here keep scooping up shares from the inpatient holders. As when this company does have news will run very fast as we have seen before.